understand
mechan
help
promot
protect
immun
respons
pathogen
major
challeng
biomed
research
import
goal
design
innov
therapeut
vaccin
strategi
natur
killer
nk
cell
directli
contribut
control
viral
replic
whether
may
help
orchestr
global
antivir
defens
larg
unknown
address
question
took
advantag
welldefin
molecular
interact
involv
recognit
mous
cytomegaloviru
mcmv
nk
cell
use
congen
mutant
mice
wildtyp
versu
genet
engin
virus
examin
consequ
antivir
cell
respons
specif
defect
abil
nk
cell
control
mcmv
system
allow
us
demonstr
knowledg
first
time
nk
cell
acceler
cell
respons
viral
infect
vivo
moreov
identifi
underli
mechan
abil
nk
cell
limit
ifnab
product
level
immunosuppress
host
achiev
earli
control
cytomegaloviru
dramat
reduc
activ
plasmacytoid
dendrit
cell
pdc
cytokin
product
preserv
convent
dendrit
cell
cdc
compart
acceler
antivir
cell
respons
convers
exogen
ifna
administr
resist
anim
ablat
cdc
delay
cell
activ
face
nk
cell
control
viral
replic
collect
data
demonstr
abil
nk
cell
respond
earli
cytomegaloviru
infect
critic
contribut
balanc
intens
innat
immun
respons
dampen
earli
immunopatholog
promot
optim
initi
antivir
cell
respons
thu
extent
nk
cell
respons
benefit
host
goe
beyond
direct
antivir
effect
extend
prevent
innat
cytokin
shock
promot
adapt
immun
develop
antivir
immun
respons
involv
orchestr
complex
network
innat
adapt
immun
cell
promot
health
diseas
natur
killer
nk
cell
plasmacytoid
dendrit
cell
pdc
convent
dendrit
cell
cdc
b
cell
cell
demonstr
import
gener
protect
immun
variou
viral
infect
howev
antivir
defens
whole
coordin
particular
function
differ
type
immun
cell
impact
shape
global
immun
respons
virus
vivo
thoroughli
understood
import
effici
nk
cell
respons
promot
favor
outcom
viral
infect
demonstr
mice
human
rapid
activ
nk
cell
infect
hallmark
potenc
innat
immun
system
effector
increas
evid
support
idea
optim
coordin
immun
respons
involv
intric
relationship
nk
cell
innat
leukocyt
exampl
sever
report
document
import
nkdc
crosstalk
reciproc
activ
cell
type
promot
antitumor
immun
recent
review
other
shown
involv
macrophag
intermediari
activ
nk
cell
via
nk
cell
nk
cell
also
shown
capac
interact
neighbor
nk
cell
well
cell
stimul
cellular
prolifer
pdc
initi
identifi
human
mice
base
uniqu
abil
cell
secret
enorm
amount
ifnab
earli
respons
viral
challeng
pdc
respond
way
consequ
abil
recogn
molecular
signatur
virus
manner
independ
pdc
infect
earli
cours
murin
cytomegaloviru
mcmv
infect
pdc
major
produc
interferon
b
ifnab
critic
host
surviv
ifnab
direct
antivir
effect
inhibit
viral
replic
infect
cell
well
convey
noninfect
cell
defens
mechan
protect
viral
infect
ifnab
also
mediat
varieti
immunoregulatori
function
either
activ
inhibitori
contribut
prolifer
nk
cell
induc
express
function
cytotox
granul
promot
cdc
phenotyp
function
matur
help
activ
antivir
cell
contrast
depend
context
ifnab
also
compromis
immun
respons
host
inhibit
dc
differenti
directli
lead
attrit
cell
inde
differ
virus
recent
suggest
induc
profound
immunosuppress
host
induc
overwhelm
level
ifnab
import
host
genotyp
effici
ifnab
antivir
function
context
infect
specif
virus
well
document
contrast
known
whether
natur
occur
differ
interact
viru
host
exist
may
shape
ifnab
respons
specif
dampen
immunosuppress
function
cytokin
detriment
host
benefici
pathogen
identif
condit
help
better
understand
physiopatholog
viral
infect
may
lead
develop
innov
treatment
fight
infect
earli
phase
mcmv
infect
tight
tempor
relationship
activ
exert
effector
function
nk
cell
pdc
product
ifnab
pdc
promot
nk
cell
prolifer
cytotox
howev
impact
nk
cell
function
pdc
respons
mcmv
remain
unexplor
goal
studi
therefor
evalu
effect
effici
nk
cell
respons
pdc
ifnab
product
develop
adapt
immun
respons
host
mice
abl
mount
nk
cell
respons
control
mcmv
replic
effici
due
express
activ
receptor
endow
nk
cell
abil
recogn
kill
viralinfect
cell
express
viral
ligand
review
although
nk
cell
balbc
strain
mice
lack
gene
strongli
activ
acquisit
cytotox
machineri
product
ifnc
earli
mcmv
infect
fail
recogn
kill
infect
cell
therefor
consid
ineffici
inbr
mous
strain
resist
sensit
mcmv
infect
nk
celldepend
manner
differ
mani
immun
paramet
includ
major
histocompat
mhc
haplotyp
well
dc
subset
frequenc
function
therefor
rigor
evalu
impact
nk
cell
respons
pdc
adapt
respons
requir
comparison
mice
genet
background
differ
abil
nk
cell
control
infect
took
advantag
fact
activ
axi
suffici
nk
cell
control
mcmv
introduc
balbc
genom
respons
pdc
cell
mcmv
therefor
compar
balbc
mice
anim
balbc
background
congen
natur
killer
complex
particular
uwaj
mice
hereaft
name
system
thu
provid
uniqu
model
studi
antivir
immun
respons
vivo
context
effici
ineffici
nk
cell
activ
absenc
broad
defect
nk
cell
develop
activ
may
affect
homeostasi
function
immun
cell
system
allow
us
demonstr
knowledg
first
time
nk
cell
acceler
cell
respons
viral
infect
vivo
moreov
identifi
underli
mechanismth
abil
nk
cell
limit
pdc
ifnab
product
level
immunosuppress
hostwhich
result
earli
control
viral
replic
trigger
requir
prolifer
accumul
nk
cell
day
mcmv
infect
therefor
first
use
nk
cell
expans
indic
show
balbc
mice
gener
nk
cell
respons
differ
qualiti
mcmv
infect
figur
next
compar
abil
balbc
mice
control
earli
viral
load
consist
report
differ
viral
load
seen
mice
lack
possess
gene
substanti
higher
viral
burden
within
spleen
balbc
mice
compar
congen
anim
figur
addit
nk
cell
deplet
mice
increas
viral
replic
level
similar
observ
balbc
anim
figur
thu
data
confirm
previou
report
demonstr
mice
mount
strong
nk
cell
respons
abl
effici
control
mcmv
replic
contrast
balbc
anim
evalu
impact
effici
antivir
nk
cell
activ
induct
ifnab
first
examin
level
cytokin
present
serum
balbc
mice
serum
level
ifnab
dramat
lower
peak
respons
day
decreas
fight
viral
infect
vertebr
develop
batteri
innat
adapt
immun
respons
aim
inhibit
viral
replic
kill
infect
cell
respons
includ
earli
product
innat
antivir
cytokin
especi
interferon
b
ifnab
activ
cytotox
lymphocyt
innat
natur
killer
nk
cell
adapt
cell
critic
antivir
defens
cytokin
cell
respons
detriment
even
fatal
host
deregul
therefor
need
better
understand
differ
arm
antivir
immun
regul
particular
nk
cell
propos
play
protect
role
varieti
viral
infect
human
underli
mechan
remain
poorli
understood
mous
model
cytomegaloviru
infect
demonstr
nk
cell
prevent
excess
product
ifnab
promot
effici
antivir
cell
respons
thu
show
nk
cell
help
promot
health
diseas
viral
infect
regul
innat
adapt
immun
respons
import
examin
human
whether
nk
cell
control
innat
cytokin
product
prevent
immunopatholog
promot
adapt
immun
herpesvirus
influenza
sar
time
point
examin
mice
compar
balbc
mice
figur
serum
level
innat
cytokin
also
significantli
lower
mice
includ
figur
tnfa
unpublish
similar
result
observ
compar
serum
cytokin
level
controltr
nk
celldeplet
mice
figur
unpublish
data
thu
system
product
ifnab
innat
cytokin
respons
mcmv
infect
high
suscept
anim
greatli
reduc
presenc
nk
cell
respons
control
viral
replic
earli
effici
mcmvinfect
immunocompet
anim
system
product
ifnab
signific
proport
come
pdc
product
infect
come
infect
cell
unpublish
data
knowledg
contribut
pdc
ifnab
innat
cytokin
product
assess
anim
balbc
genet
background
suscept
mcmv
infect
cdc
infect
mcmv
vitro
report
produc
high
level
ifnab
gener
virusinfect
cell
could
theoret
produc
cytokin
therefor
increas
system
level
ifnab
observ
balbc
anim
could
result
either
high
activ
pdc
signific
contribut
function
cell
type
high
number
infect
cell
anim
therefor
next
compar
activ
pdc
ifnab
product
balbc
anim
intracellular
stain
cytokin
ex
vivo
isol
splenocyt
figur
less
pdc
found
produc
ifnab
compar
balbc
mice
consist
previou
report
anim
pdc
sole
produc
ifnab
time
point
examin
balbc
mice
unpublish
data
pdc
cdc
contribut
product
mice
howev
high
serum
level
observ
balbc
mice
could
sole
attribut
pdc
figur
unpublish
data
therefor
high
activ
pdc
innat
cytokin
product
observ
balbc
mice
drastic
reduc
congen
anim
endow
effici
antivir
nk
cell
function
link
earli
viral
load
level
ifnab
product
pdc
perform
infect
balbc
mice
serial
dilut
viral
inoculum
lead
challeng
dose
pfumous
system
ifna
titer
anim
measur
b
splenic
leukocyt
isol
balbc
mice
analyz
frequenc
ifnab
pdc
pdc
directli
ex
vivo
number
dot
plot
repres
percent
ifnab
percent
cell
within
total
pdc
popul
one
repres
anim
group
three
mice
day
postmcmv
infect
shown
graph
repres
total
number
ifnab
pdc
pdc
present
spleen
balbc
mice
day
postmcmv
infect
result
express
mean
sd
three
mice
per
group
ten
thousand
cell
one
experi
repres
three
b
shown
p
p
detect
elisa
serum
sampl
number
pdc
produc
ifnab
flow
cytometri
figur
result
clearli
show
amount
ifnab
secret
pdc
increas
dramat
high
viral
dose
inoculum
mice
level
similar
observ
balbc
anim
differ
viru
inoculum
pfumous
suffici
switch
ifnab
product
pdc
mice
low
level
nearli
maxim
level
similar
observ
balbc
anim
low
dose
viral
infect
pfumous
balbc
mice
still
activ
nearli
maxim
pdc
cytokin
product
thu
balbc
anim
confirm
exhibit
dramat
differ
level
pdc
ifnab
product
rang
viral
inoculum
data
also
show
pdc
mice
abl
produc
high
level
ifnab
condit
stimul
high
viral
inoculum
moreov
nk
cell
deplet
mice
infect
low
viru
inoculum
also
shown
lead
dramat
increas
pdc
ifnab
product
almost
level
observ
balbc
anim
figur
altogeth
data
thu
show
abil
host
control
mcmv
replic
earli
nk
cell
respons
limit
activ
pdc
therefor
prevent
induct
high
system
level
ifnab
data
also
demonstr
pdc
mice
intrins
defici
ifnab
product
respons
mcmv
infect
high
system
level
ifnab
product
shown
lead
ablat
cdc
attrit
antigenspecif
bystand
cell
popul
infect
lymphocyt
choriomening
viru
lcmv
therefor
hypothes
high
system
level
ifnab
induc
mcmv
infect
context
ineffici
nk
cell
activ
could
lead
ablat
cdc
may
imping
develop
antivir
cell
respons
inde
previous
report
mcmv
infect
lead
sever
ablat
cdc
balbc
mice
prevent
effici
antivir
nk
cell
function
anim
howev
caus
ablat
cdc
balbc
anim
identifi
effect
ablat
develop
antivir
cell
evalu
thu
next
compar
number
dc
subset
activ
antivir
cell
differ
time
point
infect
balbc
mice
first
confirm
pdc
number
remain
homeostat
level
balbc
mice
throughout
earli
phase
mcmv
infect
sever
ablat
cdc
occur
subset
figur
contrast
presenc
effici
nk
cell
respons
mice
cdc
pdc
compart
preserv
consist
previou
observ
report
anim
next
compar
kinet
cell
expans
balbc
mice
figur
observ
signific
increas
total
cell
spleen
day
postinfect
mice
later
balbc
anim
investig
whether
acceler
expans
cell
result
faster
activ
antivir
effector
cell
first
analyz
total
splenic
cell
express
oglycosyl
activationassoci
isoform
monoclon
antibodi
mab
specif
recogn
isoform
lymphocyt
identifi
subset
effector
cell
capabl
ifnc
product
potent
cytolyt
activ
ex
vivo
acut
phase
varieti
viral
infect
observ
appear
hi
effector
cell
start
day
postinfect
mice
later
balbc
anim
figur
use
mhc
class
tetram
load
peptid
deriv
protein
mcmv
order
quantifi
subset
antivir
cell
specif
epitop
figur
observ
faster
expans
cell
mice
similar
observ
total
effector
lymphocyt
similar
result
obtain
analyz
cell
respons
anoth
viral
peptid
deriv
protein
unpublish
data
convers
splenic
leukocyt
isol
balbc
mice
analyz
frequenc
pdc
int
cdc
hi
cdc
hi
within
tcrb
popul
number
dot
plot
repres
percent
pdc
percent
cdc
percent
cdc
within
total
splenocyt
popul
one
repres
anim
group
three
mice
day
postmcmv
infect
graph
repres
total
number
million
pdc
cdc
cdc
present
spleen
balbc
mice
day
postmcmv
infect
result
express
mean
sd
three
mice
per
group
one
experi
repres
three
shown
p
p
accord
previous
report
mice
deplet
nk
cell
antibodi
treatment
observ
accumul
effector
cell
balbc
mice
later
time
point
challeng
order
investig
effector
potenti
mcmvspecif
cell
observ
day
postinfect
mice
measur
differ
paramet
associ
protect
function
antivir
cell
name
prolifer
monitor
express
marker
figur
capac
produc
ifnc
respons
antigenspecif
restimul
vitro
use
intracellular
stain
figur
elispot
figur
cytotox
potenti
measur
antigenspecif
target
cell
kill
vivo
figur
paramet
observ
acceler
acquisit
effector
function
cell
mice
compar
balbc
anim
balbc
mice
differ
whole
nk
cell
locu
includ
gene
express
sever
leukocyt
subset
sought
ensur
differ
observ
activ
kinet
cell
two
mous
strain
due
intrins
differ
reactiv
cell
ii
depend
nk
cell
activ
achiev
show
acceler
expans
cell
occur
anim
antibacteri
respons
balbc
mice
compar
listeria
monocytogen
infect
figur
ii
respons
mcmv
infect
mice
deplet
nk
cell
figur
cell
respons
balbc
mice
compar
infect
viru
oppos
infect
wildtyp
revert
virus
figur
moreov
impact
effici
nk
cell
activ
develop
antivir
cell
respons
confirm
mice
anoth
genet
background
delay
antivir
cell
activ
observ
anim
defici
nk
cell
activ
due
inactiv
associ
adaptor
molecul
compar
wildtyp
control
figur
altogeth
data
show
effici
nk
cell
respons
viral
infect
acceler
develop
effector
antivir
cell
respons
determin
whether
dramat
reduct
pdc
ifnab
product
nk
cell
function
mice
could
part
account
abil
mice
preserv
intact
cdc
compart
mount
earli
cell
respons
examin
whether
exogen
administr
cytokin
anim
could
directli
impact
initi
cdc
cell
respons
despit
effici
nk
cellmedi
control
viral
load
mcmvinfect
mice
treat
recombin
mous
ifna
describ
materi
method
dc
cell
compart
compar
controltr
balbc
mice
figur
treatment
mice
ifna
inde
led
drastic
reduct
splenic
cdc
pdc
compar
controltr
counterpart
likewis
ifna
treatment
induc
delay
expans
total
hi
tet
cell
number
figur
note
ifna
treatment
administ
mice
significantli
chang
level
viral
replic
anim
low
detect
level
infecti
viral
particl
observ
controltr
ifnainject
mice
versu
log
pfuspleen
contrast
sharpli
high
viral
replic
observ
balbc
anim
log
pfu
spleen
result
demonstr
exogen
inject
ifna
mice
suffici
decreas
number
cdc
ablat
earli
antivir
cell
respons
therefor
excess
level
ifna
direct
neg
impact
antivir
immun
cell
respons
manner
independ
level
viral
replic
host
possibl
remain
innat
cytokin
tnfa
produc
much
higher
level
balbc
compar
mice
may
also
bear
contribut
function
synergist
redund
manner
ifnab
case
data
strongli
suggest
abil
mice
preserv
intact
cdc
compart
mount
earli
cell
respons
part
due
abil
control
viral
replic
earli
without
need
host
produc
high
system
level
ifnab
altogeth
data
thu
identifi
natur
occur
differ
interact
viru
host
tilt
balanc
variou
function
ifnab
eventu
innat
cytokin
toward
condit
promot
induct
earli
adapt
immun
rather
develop
state
transient
immunosuppress
next
aim
understand
link
nk
cell
function
ifnab
product
downstream
effect
dc
cell
balbc
mice
much
higher
viral
burden
infect
mcmv
seem
plausibl
differ
viral
load
balbc
mice
could
impact
intens
dc
cell
respons
order
test
impact
extent
viral
replic
vivo
pdc
cytokin
product
antivir
cell
activ
independ
function
nk
cell
sought
strategi
control
viral
replic
effici
balbc
mice
tightli
control
time
magnitud
achiev
util
mcmv
dnscpmcmv
genet
engin
vivo
replic
effect
arrest
administr
doxycyclin
use
system
abl
design
doxycyclin
treatment
protocol
balbc
mice
close
mimic
extent
kinet
effici
nk
cellmedi
control
viral
replic
observ
inde
experiment
condit
select
viral
burden
mice
dnscpmcmvinfect
doxycyclinetr
balbc
mice
compar
differ
time
point
examin
much
lower
untreat
dnscpmcmvinfect
balbc
anim
figur
reduct
viral
burden
doxycyclinetr
dnscpmcmvinfect
balbc
anim
led
signific
strong
decreas
serum
level
pdcderiv
cytokin
ifna
figur
allow
mainten
cdc
figur
moreov
observ
acceler
activ
figur
treatment
dnscpmcmvinfect
mice
doxycyclin
effect
paramet
test
unpublish
data
thu
data
indic
mice
abil
nk
cell
dampen
innat
cytokin
product
pdc
thu
promot
optim
condit
initi
antivir
cdc
cell
respons
result
exquisit
capac
control
viral
replic
earli
effici
infect
result
studi
demonstr
effici
nk
cell
respons
promot
acceler
gener
effector
antivir
cell
infect
vivo
part
prevent
gener
high
immunosuppress
level
antivir
cytokin
thu
studi
demonstr
nk
cell
serv
effector
lymphocyt
also
regul
immun
system
function
defens
viral
infect
therefor
data
bring
import
origin
advanc
understand
contribut
nk
cell
make
immun
infecti
diseas
demonstr
control
function
anoth
critic
player
innat
antivir
respons
pdc
modul
cytokin
milieu
induc
earli
challeng
ii
acceler
gener
effector
antivir
cell
mechan
nk
cell
activ
modul
immun
respons
pathogen
summar
sever
recent
review
includ
vivo
regul
homeostasi
matur
dc
ii
prevent
detriment
persist
activ
cell
later
time
point
immun
respons
recent
also
shown
perforinmedi
nk
cell
kill
downmodul
activ
macrophag
prevent
develop
hemophagocyt
lymphohistiocytosislik
syndrom
mcmv
infect
result
demonstr
nk
cell
dramat
decreas
intens
durat
pdc
activ
control
viral
burden
prevent
product
high
system
level
ifnab
eventu
innat
cytokin
detriment
effect
host
show
mechan
also
protect
mcmvmediat
loss
splenic
cdc
report
measl
viru
lcmv
exploit
host
ifnab
respons
inhibit
cdc
develop
drive
cdc
loss
vivo
result
suggest
mcmv
also
induc
high
product
ifnab
promot
surviv
ablat
cdc
delay
activ
antivir
effector
cell
light
observ
interest
note
mcmv
develop
strategi
activ
counteract
antivir
respons
ifnab
ifnc
within
infect
cell
oppos
mechan
employ
negativestrand
rna
virus
act
shut
product
cytokin
infect
cell
pdc
inde
even
though
complet
defici
ifnab
respons
associ
dramat
increas
suscept
mice
mcmv
infect
clearli
appear
benefit
high
level
ifnab
product
host
less
brought
effici
nk
cell
respons
sinc
mice
show
viral
titer
lower
seen
balbc
mice
even
though
mice
produc
less
ifnab
thu
tempt
specul
effici
nk
cell
activ
driven
activ
receptor
abil
dampen
pdc
ifnab
product
promot
adapt
immun
direct
host
countermeasur
subvers
ifnab
respons
mcmv
altogeth
result
suggest
nk
cell
respons
govern
balanc
posit
neg
effect
ifnab
eventu
innat
cytokin
optim
orchestr
immun
respons
mcmv
data
indic
effici
nk
cell
activ
contribut
adapt
arm
immun
respons
mcmv
promot
acceler
expans
antigenspecif
cell
like
contribut
nk
cell
make
mainten
cdc
compart
data
support
role
nk
cell
control
pdc
ifnab
product
promot
antigenspecif
cell
expans
ifnab
posit
neg
effect
cell
respons
exampl
optim
expans
cell
respons
lcmv
infect
demonstr
depend
abil
cell
compart
receiv
ifnabmedi
signal
howev
within
viral
system
ifnab
also
drive
earli
attrit
antigenspecif
bystand
cell
popul
show
delay
expans
antivir
effector
cell
absenc
effici
nk
cell
respons
mcmv
occur
within
context
excess
product
ifnab
pdc
moreov
demonstr
exogen
administr
ifna
overrid
abil
effici
nk
cell
activ
promot
acceler
expans
function
antivir
cell
ifnamedi
effect
cell
expans
could
direct
downstream
consequ
loss
cdc
howev
result
suggest
direct
activ
ifnab
cell
administr
ifna
lead
complet
disappear
earli
antivir
cell
incomplet
decreas
cdc
number
although
focu
studi
data
also
show
delay
cell
respons
reach
higher
level
sustain
longer
period
time
absenc
effici
antivir
nk
cell
activ
consist
previou
observ
extend
activ
cell
compart
requir
mcmv
control
condit
like
result
poor
abil
innat
immun
system
control
viru
earli
one
could
hypothes
could
also
lead
chronic
inflamm
longterm
detriment
effect
host
includ
increas
suscept
balbc
mice
mcmvinduc
celldepend
autoimmun
diseas
myocard
thu
effici
nk
cell
respons
could
benefici
host
earli
direct
antivir
effect
also
reduc
degre
antivir
cell
activ
requir
later
control
viral
replic
therefor
indirect
cost
may
bear
health
knowledg
studi
first
demonstr
natur
occur
genet
determin
differ
interact
viru
host
tilt
balanc
variou
function
ifnab
toward
condit
promot
induct
earli
adapt
immun
rather
toward
develop
state
transient
immunosuppress
data
also
confirm
nk
cell
antivir
function
prevent
gener
chronic
state
cell
activ
later
infect
may
otherwis
lead
immunopatholog
key
question
futur
studi
determin
gener
function
nk
cell
antivir
defens
mechan
may
also
place
hiv
infect
genet
function
evid
suggest
role
variat
nk
cell
function
resist
suscept
develop
aid
detriment
effect
excess
level
ifnab
proinflammatori
cytokin
recent
suggest
initi
antivir
cell
respons
appear
delay
could
also
case
infect
highli
pathogen
strain
influenza
excess
product
proinflammatori
cytokin
shown
occur
propos
play
crucial
role
immunopatholog
nk
cell
confer
resist
recognit
infect
cell
receptor
recent
research
demonstr
human
nk
cell
abl
recogn
dc
infect
influenza
ebola
virus
correl
unregul
ifnab
respons
malfunct
switch
innat
adapt
immun
report
fatal
sar
highlight
potenti
relev
observ
varieti
viral
infect
thu
import
determin
impact
nk
cell
function
modul
innat
adapt
immun
develop
immunopatholog
model
viral
infect
moreov
result
impli
individu
suscept
viral
infect
pharmacolog
control
viral
replic
earli
benefit
directli
limit
viral
cytopathogen
also
establish
condit
better
suit
develop
balanc
protect
immun
sinc
case
mice
suscept
mcmv
infect
viral
replic
control
drug
treatment
role
nk
cell
gener
antitumor
cell
respons
link
abil
increas
inflamm
via
secret
ifnc
promot
product
dc
collect
studi
reveal
role
nk
cell
mediat
innat
cytokin
balanc
optim
gener
immun
respons
wherebi
nk
cell
requir
produc
cytokin
increas
inflamm
intrins
low
tumor
develop
prevent
excess
product
innat
cytokin
intrins
high
context
pathogen
encount
note
appar
requir
instanc
nk
cell
engag
cognat
receptormedi
interact
natur
develop
immunoregulatori
function
exampl
respons
mcmv
system
activ
nk
cell
produc
ifnc
environ
suffici
promot
control
viral
replic
associ
immunoregulatori
function
cognat
interact
could
also
enabl
nk
cell
act
direct
regul
antivir
immun
alreadi
illustr
gener
antitumor
cell
respons
respons
mcmv
express
nk
cell
dramat
increas
effici
recognit
kill
infect
cell
may
also
enabl
nk
cell
deliv
ifnc
proper
place
time
help
prime
antivir
cell
infect
mice
tripartit
interact
mcmvinfect
dc
import
cognat
interact
promot
effici
nk
cell
function
may
differ
depend
tissu
target
cell
type
exemplifi
heighten
requir
mechan
mcmv
control
lung
conclus
demonstr
effici
nk
cell
activ
contribut
optim
orchestr
innat
adapt
immun
cours
viral
infect
vivo
implic
find
extend
design
therapeut
strategi
fight
human
diseas
two
way
emphas
benefit
innat
cytokin
product
immun
cell
recruit
activ
outweigh
detriment
effect
directli
reduc
capac
host
fight
infect
well
ii
need
better
understand
take
account
complex
interact
rel
rare
cell
type
occur
physiolog
context
purpos
exploit
human
immun
system
promot
health
diseas
mice
balbc
mice
charl
river
laboratori
http
wwwcriver
com
purchas
use
studi
uwaj
refer
jackson
laboratori
http
wwwjaxorg
anim
bred
pathogenfre
breed
facil
centr
dimmunologi
de
marseillelumini
marseil
franc
experi
conduct
accord
institut
guidelin
anim
care
use
protocol
approv
french
provenc
ethic
committe
number
us
offic
laboratori
anim
welfar
assur
vivo
treatment
protocol
stock
wildtyp
smith
strain
mcmv
salivari
gland
extract
bacteri
artifici
chromosom
bac
deriv
wildtyp
dnscpmcmv
prepar
previous
describ
infect
initi
day
ip
deliveri
pfu
vivoderiv
viru
pfu
vitroderiv
viru
modest
dose
chosen
induc
lymphopenia
infect
anim
harbor
leukocyt
number
equal
greater
uninfect
control
shown
addit
dose
like
closer
physiolog
dose
reach
upon
natur
exposur
viru
contact
infect
anim
vivo
arrest
dnscpmcmv
replic
lg
doxycyclin
deliv
ip
inject
h
postinfect
follow
immedi
addit
mgml
doxycyclin
plu
sucros
drink
water
unit
recombin
mous
ifna
hycult
biotech
http
wwwhbtnl
administ
ip
inject
h
postmcmv
infect
dose
titrat
elisa
shown
correspond
ng
elisa
ifna
standard
thu
sinc
cytokin
titer
measur
elisa
serum
balbc
mice
h
postinfect
rang
ngml
volum
lymph
blood
adult
mous
roughli
estim
around
ml
dose
rmifna
inject
mice
similar
physiolog
level
cytokin
natur
induc
infect
balbc
mice
nk
cell
deplet
deliveri
lg
purifi
mab
day
premcmv
infect
day
postmcmv
infect
control
mice
treat
lg
mous
igg
jackson
immunoresearch
laboratori
http
www
jacksonimmunocom
uninfect
mice
deplet
nk
cell
schedul
day
infect
mice
assess
nk
cell
deplet
combin
antitcrb
stain
use
order
avoid
risk
underevalu
number
remain
nk
cell
may
occur
due
potenti
problem
epitop
mask
antibodi
use
immunophenotyp
one
use
deplet
nk
cell
deplet
greater
figur
isol
lymphocyt
analysi
cell
popul
spleen
minc
pass
nylon
mesh
wash
pb
mm
edta
fc
pbsedtafc
analysi
dc
popul
spleen
digest
collagenas
liberas
ci
boehring
mannheim
http
wwwrochecom
teas
apart
repeat
pipet
pbsedtafc
protocol
erythrocyt
osmot
lyse
ammonium
chlorid
treatment
thereaft
cell
suspens
kept
pb
edtafc
unless
specifi
otherwis
total
live
splenocyt
count
trypan
blue
exclus
use
hemocytomet
total
number
specif
leukocyt
subset
calcul
individu
mous
percent
cell
live
gate
total
splenocyt
total
live
splenocyt
number
cell
stimul
ifnc
product
intracellular
ifnc
detect
splenic
lymphocyt
isol
incub
yphfmptnl
peptid
agpprysri
puls
cell
ratio
h
brefeldin
sigmaaldrich
http
wwwsigmaaldrichcom
ad
last
h
cultur
cell
harvest
analyz
intracellular
ifnc
protein
threecolor
stain
follow
flow
cytometri
vivo
cytotox
assay
antigenspecif
cellmedi
cytotox
assay
describ
briefli
splenocyt
naiv
mice
costain
sigmaaldrich
either
lm
nm
nm
cfse
molecular
probe
http
probe
invitrogencom
label
cell
puls
indic
peptid
mix
equal
ratio
transfer
iv
total
cell
indic
group
mice
lymphocyt
isol
spleen
recipi
mice
h
posttransf
analyz
transfer
cell
level
cfse
express
unpuls
peptidepuls
cell
percent
kill
within
gate
calcul
peptidepuls
infect
unpuls
infect
peptidepuls
uninfect
unpuls
uninfect
quantif
viral
titer
serum
cytokin
level
spleen
homogen
viral
titer
determin
plaqu
assay
use
mous
embryon
fibroblast
centrifug
enhanc
cell
serum
collect
indic
time
point
cytokin
level
determin
elisa
ifna
pbl
biomed
laboratori
http
wwwinterferonsourcecom
r
system
http
wwwrndsystemscom
per
manufactur
instruct
ab
reagent
clone
clone
clone
tcrballophycocyanin
clone
ifncallophycocyanin
clone
clone
streptavidinp
purchas
bd
pharmingen
http
wwwbdbiosciencescom
clone
purchas
caltag
http
wwwcaltagcom
clone
purchas
novocastra
http
www
visionbiocom
purifi
rat
antimous
ifna
clone
antiifnb
clone
purchas
tebubio
http
wwwtebubiocom
mab
provid
scheringplough
http
wwwscheringploughcom
conjug
alexa
use
kit
molecular
probe
isotyp
control
mab
purchas
appropri
manufactur
follow
tetram
conjug
pe
obtain
nih
tetram
facil
atlanta
georgia
unit
state
yphfmptnl
agpprysri
abovement
reagent
use
fac
analysi
studi
flow
cytometr
analysi
cell
first
incub
mab
min
cell
stain
mab
specif
cell
surfac
marker
isotyp
control
min
cell
wash
fix
paraformaldehyd
pb
intracellular
stain
ifnc
perform
use
cytofix
cytoperm
kit
bd
pharmingen
intracellular
stain
ifnab
perform
previous
describ
depend
experi
event
collect
facscalibur
data
acquir
analyz
use
cellquest
softwar
bd
bioscienc
isotyp
control
use
set
gate
present
fac
analys
statist
analys
statist
analys
perform
microsoft
excel
microsoft
corpor
http
wwwmicrosoftcom
use
student
twotail
test
mean
standard
deviat
sd
calcul
graph
visual
absent
error
bar
small
depict
base
scale
yaxi
